We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current INVO market cap is 2.85M. The company's latest EPS is USD -2.1096 and P/E is -0.36.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 348k | 316k | 975k | 1.38M | 1.58M |
| Operating Income | -2.33M | -2.06M | -894k | -1.51M | -947k |
| Net Income | -2.55M | -2.24M | -1.25M | -2M | -1.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.48M | 1.04M | 4.16M | 822k | 3.02M |
| Operating Income | -1.79M | -5.52M | -5.22M | -10.63M | -6.77M |
| Net Income | -2.17M | -8.35M | -6.66M | -10.89M | -8.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.15M | 6.64M | 19.48M | 20.89M | 18.32M |
| Total Liabilities | 6.06M | 8.34M | 19.1M | 20M | 18.31M |
| Total Equity | 88k | -1.71M | 373k | 893k | 10k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.8M | 10.95M | 10.47M | 4.1M | 20.89M |
| Total Liabilities | 5.51M | 5.2M | 3.16M | 5.08M | 20M |
| Total Equity | -3.71M | 5.74M | 7.31M | -978k | 893k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.15M | -2.79M | -4.04M | -4.76M | -260k |
| Investing | -8k | -270k | -2.53M | -2.49M | -24k |
| Financing | 3.26M | 3.09M | 7.53M | 7.39M | 527k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.37M | -4.78M | -6.03M | -6.6M | -4.76M |
| Investing | -115k | -187k | -2.15M | -81k | -2.49M |
| Financing | -230k | 13.82M | 3.77M | 1.09M | 7.39M |
| Market Cap | 2.85M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 0.95 |
| Price to Cash Ratio | 12.32 |
| Price to Book Ratio | 3.2 |
| Dividend Yield | - |
| Shares Outstanding | 3.81M |
| Average Volume (1 week) | 26.7k |
| Average Volume (1 Month) | 39.95k |
| 52 Week Change | -75.98% |
| 52 Week High | 7.1999 |
| 52 Week Low | 0.50 |
| Spread (Intraday) | 0.04 (4.91%) |
| Company Name | INVO BioScience Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.invobioscience.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
